This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
electric-vehicles: Archive
Carvana Anticipates Margin Improvement: What's Driving the Growth?
by Zacks Equity Research
CVNA posts record adjusted EBITDA in the first quarter of 2025, nearly doubling peers' margins, and expects more gains ahead.
ANNegative Net Change LADNegative Net Change CVNANegative Net Change
auto-tires-trucks electric-vehicles
Will Rivian's Charging Update Help It Catch Up With Rivals?
by Zacks Equity Research
RIVN's latest software update boosts charging speeds, adds manual preconditioning and sharpens energy tracking features.
TSLANegative Net Change VWAGYNegative Net Change RIVNPositive Net Change
auto-tires-trucks electric-vehicles
Tesla Losing Steam in Europe: What's Impeding Its Growth?
by Zacks Equity Research
TSLA sales slid for a fifth straight month in Europe, hit by political backlash, old models and rising competition.
TSLANegative Net Change VWAGYNegative Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles
Should You Buy Sterling Infrastructure (STRL) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla Robotaxi Nearing Launch: Buy, Hold or Sell the Stock Now?
by Rimmi Singhi
TSLA jumps 23% in the past month on robotaxi hype, but with a few launch details and fading EV sales, is the rally built to last?
TSLANegative Net Change GOOGLPositive Net Change BYDDYPositive Net Change
artificial-intelligence autonomous-vehicles electric-vehicles
NIO's May Deliveries Rise 13% Y/Y But Is That Good Enough?
by Zacks Equity Research
NIO delivered over 23K EVs in May, but weaker growth and shifting brand dynamics may test its 2025 sales goal.
NIOPositive Net Change LIPositive Net Change XPEVPositive Net Change
electric-vehicles
Shortage of Rare-Earth Magnets Endangers US Vehicle Production
by Lavina Shahu
Rare-earth magnet supply shortages from China threaten U.S. auto production, putting key parts and plant operations at risk.
FNegative Net Change GMPositive Net Change VWAGYNegative Net Change
auto-tires-trucks electric-vehicles
Strattec Security (STRT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
STRTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
TMDXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
VIGLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Marqeta (MQ) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
MQPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Coeur Mining (CDE) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
CDEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ouster, Inc. (OUST) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
OUSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
United Microelectronics Corporation (UMC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
UMCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
General Motors to Make an Investment of $888M in Tonawanda Plant
by Zacks Equity Research
GM plans to invest $888 million in the Tonawanda Propulsion plant to build next-generation V-8s with better fuel efficiency and performance.
GMPositive Net Change STRTNegative Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
NIO Stock Sinks Ahead of Q1 Earnings: Is This a Buying Opportunity?
by Rimmi Singhi
As NIO gears up to report Q1 earnings on Tuesday, let's find out how the expectations stack up. Also, is it the right time to buy the stock?
NIOPositive Net Change LIPositive Net Change XPEVPositive Net Change
electric-vehicles
3 Technology Services Stocks Hitting New 52-Week Highs: CCRD, DAVE, MVST
by Shaun Pruitt
Several technology services stocks have hit new 52-week highs this week and look poised for more upside after crushing their Q1 expectations earlier in the month.
DAVEPositive Net Change MVSTPositive Net Change CCRDPositive Net Change
business-services earnings electric-vehicles fin-tech finance investing tech-stocks
IO Biotech, Inc. (IOBT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IOBTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
China's EV Market Faces Brutal Test After BYD's Aggressive Price Cuts
by Rimmi Singhi
BYD's aggressive price cuts are rattling China's EV giants. Margin squeeze and fierce competition threaten the sector's future.
NIOPositive Net Change BYDDYPositive Net Change LIPositive Net Change XPEVPositive Net Change
electric-vehicles
Nissan Resorts to e-Power Technology to Reshape Vehicle Lineup
by Zacks Equity Research
NSANY relies on e-Power technology as it focuses on cutting expenses and reshaping its vehicle lineup after reporting a loss in fiscal 2024.
NSANYNegative Net Change STRTNegative Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
Geely's Subsidiary to Cut 3,000 Jobs Amid High Costs and Weaker Demand
by Zacks Equity Research
GELYY's subsidiary plans to reduce 3,000 jobs, mostly white-collar, as high costs, slowing EV demand and growing trade uncertainty engulf it.
STRTNegative Net Change GELYYPositive Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
NIO vs. TSLA: Which EV Stock Has More Charge for the Future?
by Rimmi Singhi
NIO and Tesla face challenges, but one seems better placed now. We break down what drives each and which EV stock deserves your attention today.
TSLANegative Net Change NIOPositive Net Change
electric-vehicles
Toyota's 2026 RAV4 SUV to Have Hybrid and Plug-In Hybrid Options Only
by Zacks Equity Research
TM's 2026 RAV4 goes all-in on electrification with hybrid and plug-in options only, plus new designs, more power and upgraded tech features.
TMPositive Net Change STRTNegative Net Change RACEPositive Net Change MGDDYNegative Net Change
auto-tires-trucks electric-vehicles
BYD's EV Sales in Europe Surpass Tesla for the First Time
by Zacks Equity Research
BYDDY's EV sales in Europe increase 169% year over year in April, overtaking Tesla for the first time.
TSLANegative Net Change STRTNegative Net Change RACEPositive Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles
MGIC Investment (MTG) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MTGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines